newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box® for potential development of